![](https://www.mintz.com/sites/default/files/styles/bio_banner/public/media/images/2018-04-19/Professional_Cropped_Dwyer_Tara_Mintz.jpg?itok=SSejZhGG)
Tara enjoys working with managed care organizations, pharmaceutical services providers such as PBMs, and integrated delivery systems, and companies that invest in them, on matters relating to compliance with federal health care program regulations, federal and state fraud, waste and abuse laws and plan benefits.
She works closely with Medicare Advantage Organizations (MAOs) and Medicare Part D Plan Sponsors, including Employer Group Waiver Plans (EGWPs), and first tier and downstream entities to address regulatory and compliance matters that arise as a result of participating in Medicare Parts C and D. Tara often advises clients on matters relating to plan bids, medical loss ratio reporting, drug pricing in both Medicare Part B and Part D and direct and indirect remuneration (DIR) reporting. She regularly counsels clients regarding risk adjustment systems and practices needed to support them. Tara also actively engages with CMS on behalf of clients on many matters.
She also works closely with discount medical and pharmacy plan operators (DMPOs) on matters relating to compliance with state laws and provider contracting.
Tara uses her substantive day-to-day compliance experience to assist clients in litigation matters and transactions.
Tara has extensive experience preparing and negotiating complex services agreements for and between MAOs, providers, PBMs, pharmacies, wholesalers, manufacturers, and DMPOs.
viewpoints
Health Law Diagnosed — Transactions Part 2: The Role of Health Regulatory Diligence and How to Prepare for a Sell-Side Transaction
March 24, 2022 | Podcast | By Tara E. Dwyer, Xavier Hardy, Bridgette Keller, Lauren Moldawer, Cassandra Paolillo, Kate Stewart
Health regulatory diligence has the ability to make or break a deal. Listen to hear about our team’s firsthand experience in the importance of conducting health regulatory diligence and best practices in preparing for a sell-side transaction.
Supreme Court Holds that ERISA Does Not Preempt Arkansas PBM Law: The Impact on Employer Sponsored Group Health Plans
December 31, 2020 | Blog | By Tara E. Dwyer
Post-Election 2020 - Health Care Preview
November 23, 2020 | Blog | By Alexander Hecht, Anthony DeMaio, Tara E. Dwyer
CMS Proposes Significant Changes to Medicare Advantage & Part D for 2021 and Beyond, Part 2: CMS Proposes to Codify Supplemental Benefit Rules and Update MLR
February 25, 2020 | Blog | By Tara E. Dwyer, Lauren Moldawer
CMS Proposes Significant Changes to Medicare Advantage & Part D for 2021 and Beyond, Part 1: Updates to the Star Rating System and Suspension of the Past Performance Methodology
February 13, 2020 | Blog | By Tara E. Dwyer, Lauren Moldawer
CMS Proposes Significant Changes to Medicare Advantage and Part D for 2021 and Beyond
February 7, 2020 | Blog | By Tara E. Dwyer
Health Care: A Clearer Vision in 2020? Don’t Bet On It
January 15, 2020 | Blog | By Tara E. Dwyer
Administration Finally Releases Proposed Drug Importation Policies for Stakeholder and Public Comments
December 27, 2019 | Blog | By Joanne Hawana, Tara E. Dwyer
CMS Finalizes Rule Requiring Disclosure of Drug Prices in TV Ads
May 9, 2019 | Blog | By Tara E. Dwyer
HHS Proposes to Remove Drug Rebate Protections
February 1, 2019 | Blog | By Theresa Carnegie, Tara E. Dwyer
News & Press
PBM Takeaways From Proposed Telehealth Flexibility Bill
June 18, 2024
Mintz Facilitates $3.7 Billion Deal For The Cigna Group
January 31, 2024
The Cigna Health Group signed a deal selling its Medicare businesses to Health Care Service Corporation (HCSC) for $3.7 billion. A Mintz team led by Tara Dwyer and Lauren Moldawer acted as regulatory counsel to The Cigna Group on the sale. In the deal, which is expected to close in the first quarter of 2025, HCSC will acquire Cigna’s Medicare lines including Medicare Advantage, Medicare supplement, and Medicare drug plans, as well as CareAllies, a unit that works with physician groups and other healthcare providers.
Lawsuits, Tax Fuel Doubt As Medicare Preps Drug Pricing Talks
August 25, 2023
Member Tara Dwyer spoke to Bloomberg Law and discussed potential roadblocks delaying Medicare's plans for negotiating lower drug prices.
Mintz is pleased to announce that 120 firm attorneys have been recognized as leaders by Best Lawyers® in the 2024 edition of The Best Lawyers in America©.
'Many Legal Challenges' Loom As HHS Inks $4.7B Audit Rule
January 30, 2023
Mintz Member Tara Dwyer was quoted in Law360 examining the release of a Health and Human Services rule which prompted backlash and predictions of litigation.
Supreme Court Holds that ERISA Does Not Preempt Arkansas PBM Law: The Impact on Employer Sponsored Health Plans
February 5, 2021
Drug Intermediaries Threaten Lawsuits to Preserve Cut of Prices
November 23, 2020
Mintz Practice Groups and Attorneys Garner Top Rankings in 2020 Edition of The Legal 500 United States
June 12, 2020
Proposed changes to Medicare Advantage audits could put insurers on the hook for billions
October 29, 2018
Mintz Promotes Six Attorneys to Member
May 23, 2018
Events & Speaking
Legal, Regulatory, and Compliance Summit on Medicare Advantage
American Conference Institute
Nashville, TN
![Conference Reference Image](https://www.mintz.com/sites/default/files/styles/social/public/media/images/2020-04-23/CONFERENCE_vfinal.jpg?itok=1eZh6mA0)
3rd Annual Mintz /ML Strategies Pharmacy & Pharmaceutical Industry Summit
Mintz and ML Strategies
Boston, MA
![Conference Reference Image](https://www.mintz.com/sites/default/files/styles/social/public/media/images/2020-04-23/CONFERENCE_vfinal.jpg?itok=1eZh6mA0)
Recognition & Awards
Best Lawyers in America: Health Care (2024)
Chambers USA: District of Columbia – Healthcare (2024)
Included on the Washington DC Super Lawyers Rising Stars: Health Care list (2016 - 2021)
The Legal 500 United States for Healthcare: Service Providers (2019-2020, 2024)
Order of the Coif
ABA-BNA Award for Excellence in the Study of Health Law